Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126400211 | 12640021 | 1 | I | 20160727 | 20160810 | 20160810 | EXP | US-MYLANLABS-2016M1031700 | MYLAN | HOFFMANN MS, OVERMAN MJ, NATES JL. ACUTE BENZODIAZEPINE TOXICITY EXACERBATED BY CONCOMITANT ORAL OLANZAPINE. J-COMMUNITY-SUPPORT-ONCOL 2016;14(4):178-179. | 0.00 | Y | 0.00000 | 20160810 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126400211 | 12640021 | 1 | PS | LORAZEPAM. | LORAZEPAM | 1 | Oral | 1MG 2 TO 3 TIMES DAILY, BEEN RECEIVING FOR SEVERAL MONTHS | U | U | 77657 | ||||||||
| 126400211 | 12640021 | 2 | SS | LORAZEPAM. | LORAZEPAM | 1 | Oral | 1MG 2 TO 3 TIMES DAILY, BEEN RECEIVING FOR SEVERAL MONTHS | U | U | 77657 | ||||||||
| 126400211 | 12640021 | 3 | SS | LORAZEPAM. | LORAZEPAM | 1 | Intravenous (not otherwise specified) | 1MG, AT 3:45 PM | U | U | 77657 | ||||||||
| 126400211 | 12640021 | 4 | I | OLANZAPINE. | OLANZAPINE | 1 | Oral | 10MG DAILY FOR 10 DAYS | U | U | 0 | ||||||||
| 126400211 | 12640021 | 5 | I | OLANZAPINE. | OLANZAPINE | 1 | Oral | 10MG DAILY FOR 10 DAYS | U | U | 0 | ||||||||
| 126400211 | 12640021 | 6 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 2000MG/ME2, OVER 46 HOURS | U | U | 0 | ||||||||
| 126400211 | 12640021 | 7 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous (not otherwise specified) | 60MG/ME2, OVER 2 HOURS | U | U | 0 | ||||||||
| 126400211 | 12640021 | 8 | SS | FOLINIC ACID | LEUCOVORIN | 1 | Unknown | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126400211 | 12640021 | 1 | Vomiting |
| 126400211 | 12640021 | 2 | Anxiety |
| 126400211 | 12640021 | 3 | Premedication |
| 126400211 | 12640021 | 4 | Vomiting |
| 126400211 | 12640021 | 5 | Nausea |
| 126400211 | 12640021 | 6 | Pancreatic carcinoma metastatic |
| 126400211 | 12640021 | 7 | Pancreatic carcinoma metastatic |
| 126400211 | 12640021 | 8 | Pancreatic carcinoma metastatic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126400211 | 12640021 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126400211 | 12640021 | Delirium | |
| 126400211 | 12640021 | Hypotension | |
| 126400211 | 12640021 | Labelled drug-drug interaction medication error | |
| 126400211 | 12640021 | Respiratory depression | |
| 126400211 | 12640021 | Toxicity to various agents | |
| 126400211 | 12640021 | Unresponsive to stimuli |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |